GB201005822D0 - Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity - Google Patents
Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicityInfo
- Publication number
- GB201005822D0 GB201005822D0 GBGB1005822.0A GB201005822A GB201005822D0 GB 201005822 D0 GB201005822 D0 GB 201005822D0 GB 201005822 A GB201005822 A GB 201005822A GB 201005822 D0 GB201005822 D0 GB 201005822D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- iminosugars
- dependent cell
- mediated cytotoxicity
- enhance antibody
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1005822.0A GB201005822D0 (en) | 2010-04-08 | 2010-04-08 | Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1005822.0A GB201005822D0 (en) | 2010-04-08 | 2010-04-08 | Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201005822D0 true GB201005822D0 (en) | 2010-05-26 |
Family
ID=42235976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1005822.0A Ceased GB201005822D0 (en) | 2010-04-08 | 2010-04-08 | Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201005822D0 (en) |
-
2010
- 2010-04-08 GB GBGB1005822.0A patent/GB201005822D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1183802A1 (en) | Therapeutic oral composition | |
IL233216A0 (en) | Oral care compositions | |
ZA201306292B (en) | Oral health improving compositions | |
HK1256896A1 (en) | Methods and compositions to enable multiplex cold-pcr | |
EP2635254A4 (en) | Compositions and methods relating to reduced mucoadhesion | |
SG11201401056SA (en) | Oral care compositions | |
EP2509568A4 (en) | Skin care compositions | |
LT2616064T (en) | Ready to use ketorolac formulations | |
EP2659878A4 (en) | Skin cleanser composition | |
PL3178472T3 (en) | Oral formulations of methylnaltrexone | |
HK1203432A1 (en) | Oral care compositions | |
HK1200345A1 (en) | Compositions for skin exfoliation and use thereof | |
HK1203402A1 (en) | Oral care compositions | |
EP2752186A4 (en) | Skin cleanser composition | |
SG11201402840RA (en) | Oral care compositions | |
HK1200705A1 (en) | Oral care compositions | |
HK1203385A1 (en) | Oral care compositions | |
EP2752185A4 (en) | Skin cleanser composition | |
EP2552210A4 (en) | Formulations of mazindol | |
ZA201304087B (en) | Oral compositions | |
SI2407155T1 (en) | Formulations of inecalcitol | |
HK1203386A1 (en) | Oral care compositions | |
EP2640418A4 (en) | Immunogenic compositions | |
GB201014317D0 (en) | Preparation of electrode compositions | |
GB201005822D0 (en) | Use of iminosugars to enhance antibody-dependent cell-mediated cytotoxicity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |